Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest Breast cancer treatment Stories

2014-04-08 13:04:46

Trial identifies breast cancer patients likely to benefit from experimental drug In an innovative clinical trial led by UC San Francisco, the experimental drug neratinib along with standard chemotherapy was found to be a beneficial treatment for some women with newly diagnosed, high-risk breast cancer. Additionally, researchers learned that an algorithm used in the adaptive, randomized trial known as I-SPY 2 was highly effective at predicting the success of the treatment regimen in the...

2014-04-08 12:32:28

Champions TumorGrafts(TM) Provide Accurate Predictions of Treatments' Efficacy in 81 Percent of Evaluated Patients with Advanced Sarcoma HACKENSACK, N.J., April 8, 2014 /PRNewswire/ -- Data published in Cancer show the use of personalized patient-derived xenografts, or mouse avatars, accurately predicted treatment efficacy in all evaluated patients with advanced sarcoma. The results support the predictive capabilities of Champions TumorGrafts®, developed by Champions Oncology (OTC:...

2014-04-08 12:31:44

Metronomic algorithms for targeted therapy to improve value of response and "failed drugs" for "resistant women's cancers" NEW YORK, April 8, 2014 /PRNewswire/ -- The following will be presented this week at the annual meeting of the American Association of Cancer Research, San Diego. Dr Howard Bruckner will present accumulating evidence describing a novel successful treatment for patients with resistant ovarian cancer. Low dose chemotherapy as cores, selected drug combinations,...

2014-04-07 12:47:39

A new genetic "signature" to identify prostate cancer patients who are at high risk of their cancer recurring after surgery or radiotherapy has been developed by researchers in Canada, the 33rd conference of the European Society for Radiotherapy and Oncology (ESTRO33) in Vienna will hear today (Saturday). Professor Robert Bristow will tell the conference that although surgery and precision radiotherapy are the mainstays of treatment for cancer that is confined to the prostate, the cancer...

2014-04-04 23:34:52

Cianna Medical, Inc.: Strut-based breast cancer radiation treatment could expand options for DCIS patients. Aliso Viejo, Calif. (PRWEB) April 03, 2014 Cianna Medical, Inc., a women’s health company, today announced the results of a retrospective study of breast cancer patients with ductal carcinoma in situ (DCIS) treated with SAVI® breast brachytherapy. Researchers reported excellent local control, with recurrence rates that appear to be equivalent to those expected for whole...

2014-04-01 12:31:21

Surgery for "operable" tumor is also possible but may not be necessary NEW YORK, April 1, 2014 /PRNewswire-USNewswire/ -- Hall of Fame quarterback Jim Kelly will start chemotherapy and radiation treatments targeting cancer cells in his maxillary sinus and adjacent tissues next week, Peter D. Costantino, MD, executive director of Lenox Hill Hospital's New York Head & Neck Institute, reported today. Mr. Kelly will be receiving a single dose of chemotherapy at Lenox Hill Hospital,...

2014-03-31 09:54:57

UT Southwestern Medical Center researchers are developing a new predictive tool that could help patients with breast cancer and certain lung cancers decide whether follow-up treatments are likely to help. Dr. Jerry Shay, Vice Chairman and Professor of Cell Biology at UT Southwestern, led a three-year study on the effects of irradiation in a lung cancer-susceptible mouse model. When his team looked at gene expression changes in the mice, then applied them to humans with early stage cancer,...

2014-03-28 23:00:12

One woman’s successful fight against breast cancer becomes another person’s reason for hope and inspiration. New York (PRWEB) March 29, 2014 “Are You Kidding Me?” is about being diagnosed with breast cancer and all the wonderful games author Lucy Morrison got to play. It starts out with the mammogram and further testing and continues with surgery, radiation, and chemotherapy. She was fortunate to have a less-invasive type of cancer and did not need the kind of chemotherapy that...

2014-03-25 12:29:41

Perjeta and Kadcyla are Reshaping the Treatment Algorithm for Patients with HER2-Positive Breast Cancer, According to Findings from Decision Resources Group BURLINGTON, Mass., March 25, 2014 /PRNewswire/ -- Decision Resources Group finds that efficacy more than any other factors drives oncologists' prescribing of targeted therapies for breast cancer and, according to the majority of surveyed oncologists, the escalating overall cost of drug treatment for breast cancer has little or no impact...

2014-03-06 23:24:30

Cianna Medical, Inc: Results could expand treatment options for more women with early-stage breast cancer. Aliso Viejo, CA (PRWEB) March 06, 2014 Cianna Medical, Inc., a women’s health company, today announced favorably low recurrence rates – even for younger women – as part of a retrospective analysis of 673 patients with invasive breast cancer treated with the SAVI® breast brachytherapy applicator. SAVI is a strut-based device that delivers a form of accelerated partial...